Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Indaptus Therapeutics, Inc. (INDP) had Income from Continuous Operations of $-15.02M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-15.02M |
|
-- |
|
-- |
|
$15.37M |
|
$-15.37M |
|
$0.34M |
|
$-15.02M |
|
$-15.02M |
|
$-15.02M |
|
|
Income from Continuous Operations |
$-15.02M |
$-15.02M |
|
$-15.02M |
|
$-15.37M |
|
$-15.37M |
|
9.36M |
|
9.36M |
|
$-1.61 |
|
$-1.61 |
|
| Balance Sheet Financials | |
$6.62M |
|
-- |
|
$0.72M |
|
$7.34M |
|
$3.39M |
|
-- |
|
-- |
|
$3.39M |
|
$3.94M |
|
$3.94M |
|
$3.94M |
|
12.01M |
|
| Cash Flow Statement Financials | |
$-12.32M |
|
-- |
|
$4.75M |
|
$13.36M |
|
$5.79M |
|
$-7.58M |
|
$2.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.95 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-380.80% |
|
-380.80% |
|
-204.69% |
|
-380.80% |
|
$0.33 |
|
$-1.32 |
|
$-1.32 |
|